ID

41201

Description

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01263704

Link

https://clinicaltrials.gov/show/NCT01263704

Keywords

Versions (1)
  1. 7/12/20 7/12/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 12, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphocytic Leukemia, Chronic NCT01263704

English

Eligibility Lymphocytic Leukemia, Chronic NCT01263704

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/= 65 years of age
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
previously untreated b-cell chronic lymphocytic leukemia (cll)
Description

B-cell chronic lymphocytic leukemia Untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0475774
UMLS CUI [1,2]
C0332155
binet stage c or active binet stage a and b disease
Description

Binet Staging System

Data type

boolean

Alias
UMLS CUI [1]
C1511118
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment for cll
Description

Prior Therapy Chronic Lymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0023434
cll with transformation (richter's syndrome)
Description

Chronic Lymphocytic Leukemia | Richter's syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2]
C0349631
suspected or known cns involvement of cll
Description

Central Nervous System Involvement Chronic Lymphocytic Leukemia Suspected | Central Nervous System Involvement Chronic Lymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0023434
UMLS CUI [1,3]
C0750491
UMLS CUI [2,1]
C4050309
UMLS CUI [2,2]
C0023434
impaired renal or hepatic function
Description

Renal Insufficiency | Liver Dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0086565
hiv positivity, active hepatitis b/c or hbv surface antigen positive, or any active or uncontrolled infections
Description

HIV Seropositivity | Hepatitis B | Hepatitis C | Hepatitis B surface antigen positive | Communicable Disease | Communicable Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
UMLS CUI [4]
C0149709
UMLS CUI [5]
C0009450
UMLS CUI [6,1]
C0009450
UMLS CUI [6,2]
C0205318
patients with anti-hbv core antibodies (past infection with hbv) but who are negative for hbvsag (either anti-hbs ab positive or negative) and are positive for hbv-dna by pcr analysis
Description

Antibody to hepatitis B core antigen | Hepatitis B In the past | Hepatitis B surface antigen negative | Hepatitis B surface antibody positive | Hepatitis B surface antigen negative | Hepatitis B DNA Positive Polymerase Chain Reaction

Data type

boolean

Alias
UMLS CUI [1]
C0312631
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C1444637
UMLS CUI [3]
C0919711
UMLS CUI [4]
C0149708
UMLS CUI [5]
C0919711
UMLS CUI [6,1]
C5206277
UMLS CUI [6,2]
C0032520
concomitant diseases requiring chronic steroid administration
Description

Comorbidity Requirement Steroid therapy chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0149783
UMLS CUI [1,4]
C0205191
active second malignancy within the 2 years prior to study (except for non-melanoma skin cancer and in situ cervix or breast or prostate carcinoma)
Description

Second Primary Cancer | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of female breast | Exception Carcinoma in situ of prostate

Data type

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0686288
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0154088
ecog performance status >/= 3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Back to the top of the page

Similar models

Eligibility Lymphocytic Leukemia, Chronic NCT01263704

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >/= 65 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
B-cell chronic lymphocytic leukemia Untreated
Item
previously untreated b-cell chronic lymphocytic leukemia (cll)
boolean
C0475774 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Binet Staging System
Item
binet stage c or active binet stage a and b disease
boolean
C1511118 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Chronic Lymphocytic Leukemia
Item
prior treatment for cll
boolean
C1514463 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
Chronic Lymphocytic Leukemia | Richter's syndrome
Item
cll with transformation (richter's syndrome)
boolean
C0023434 (UMLS CUI [1])
C0349631 (UMLS CUI [2])
Central Nervous System Involvement Chronic Lymphocytic Leukemia Suspected | Central Nervous System Involvement Chronic Lymphocytic Leukemia
Item
suspected or known cns involvement of cll
boolean
C4050309 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
C0750491 (UMLS CUI [1,3])
C4050309 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
Renal Insufficiency | Liver Dysfunction
Item
impaired renal or hepatic function
boolean
C1565489 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
HIV Seropositivity | Hepatitis B | Hepatitis C | Hepatitis B surface antigen positive | Communicable Disease | Communicable Disease Uncontrolled
Item
hiv positivity, active hepatitis b/c or hbv surface antigen positive, or any active or uncontrolled infections
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0149709 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C0009450 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
Antibody to hepatitis B core antigen | Hepatitis B In the past | Hepatitis B surface antigen negative | Hepatitis B surface antibody positive | Hepatitis B surface antigen negative | Hepatitis B DNA Positive Polymerase Chain Reaction
Item
patients with anti-hbv core antibodies (past infection with hbv) but who are negative for hbvsag (either anti-hbs ab positive or negative) and are positive for hbv-dna by pcr analysis
boolean
C0312631 (UMLS CUI [1])
C0019163 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
C0919711 (UMLS CUI [3])
C0149708 (UMLS CUI [4])
C0919711 (UMLS CUI [5])
C5206277 (UMLS CUI [6,1])
C0032520 (UMLS CUI [6,2])
Comorbidity Requirement Steroid therapy chronic
Item
concomitant diseases requiring chronic steroid administration
boolean
C0009488 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,3])
C0205191 (UMLS CUI [1,4])
Second Primary Cancer | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of female breast | Exception Carcinoma in situ of prostate
Item
active second malignancy within the 2 years prior to study (except for non-melanoma skin cancer and in situ cervix or breast or prostate carcinoma)
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0686288 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0154088 (UMLS CUI [5,2])
ECOG performance status
Item
ecog performance status >/= 3
boolean
C1520224 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial